Detailed analyses of simian immunodeficiency virus (SN)-specific cytotoxic T lymphocyte (CTL) responses in vaccinated and
Even though cytotoxic T lymphocytes (CTL) are believed to contribute to the control of human and animal viral infections, their role in the host defense against lentiviruses has not been firmly established'. Infection of macaques with several strains or clones of simian immunodeficiency virus (SIV)mac shows remarkable similarities with human immunodeficiency virus (HIV) infection of humans2. Following SIV inoculation, a burst of virus replication is observed, which rapidly subsides in coincidence with the development of antiviral immune responses3. The subsequent course of the infection varies considerably among macaques: some animals rapidly develop an AIDS-like disease and die within few weeks or months, whereas others may remain asymptomatic for > 3 years. This individual variability, combined with the opportunity to define parameters of infection such as strain, dose and route of virus inoculation, may prove valuable for clarifying the role of CTL immunity in the control of lentiviral infections.
We4 and others5,6 have reported recently that vaccine-induced SIV Env-, Gag-, or Nef-specific CTL failed to protect macaques upon challenge with cellfree SIVmac. In the same model, however, Gallimore et al. ' found an inverse correlation between the frequency of vaccine-induced SIV Nef-specific CTL precursors (CTLp) and peak virus load measured after challenge. These findings indicate that CTL may not be able to prevent or control HIV or SIV infection, unless stringent qualitative and quantitative requirements are met. Detailed analyses of CTL responses in both vaccinated and infected macaques may help to clarify these 
MATERIALS AND METHODS

Animals
The study included eight colony-bred juvenile (1.5-3.5 years) cynomolgus macaques seronegative for SIV, type D simian retrovirus (SRV) and simian T cell leukaemia virus-l (STLV-I). Four monkeys (designated K77*, K80*, K83* and K88*) were immunized with an SIV Env-lscoms, Gag-lscoms and Nef-lipopeptides subunit vaccine, as described4. The other four monkeys (K73, K79, K66 and K71) were naive at the time of SIV infection.
Animals were inoculated intravenously with 50 monkey median infectious doses of cell-free SlVmacJ5, a pathogenic molecular clone derived from SlVmac32H and grown on rhesus peripheral blood mononuclear cells (PBMC)". Infection was confirmed by virus isolation", antibody detection in ELlSA and nested-Gag PCRIS. 
PBMC preparation
Bulk culture conditions
Bulk assays were done with either unstimulated or restimulated PBMC. For antigenic stimulation, PBMC (2.5 x lo4 per well) in R-10 were cultured for 14 days in 96-well round-bottomed plates with SIV Gag or Tat APC (lo4 per well) and autologous irradiated (2500 rad) feeder PBMC (lo4 per well). Cultures were supplemented with 10 U ml-' recombinant interleukin (IL)-2 (rlL-2) from day 3, and restimulated with lo4 per well APC on day 7. During the second cycle of stimulation the culture medium was enriched with 10% supernatant from concanavalin A (ConA)-stimulated blasts. In some experiments, PBMC (10' ml-') were cultured for lo-14 days with autologous irradiated PHA-blasts infected with SlVmac32H(JS) (lo5 ml-'), as described by Gotch et af.". For mitogenic stimulation, PBMC ( lo6 ml-') were cultured for 3 days with ConA (5 pg ml-'), washed, and expanded with rlL-2 (20 U ml-') for 4-11 days. Effector cells were assayed for cytotoxicity in duplicate or triplicate wells at indicated effector-to-target cell (E:T) ratios.
Limiting dilution culture conditions
Limiting dilution assays were done with either unstimulated or restimulated PBMC, to estimate CTLIX and CTLp frequencies respectively. PBMC restimulation was performed as described for bulk assays. The optimal limiting dilution assay parameters, including numbers and ranges of dilutions, and numbers of replicate wells, were predetermined for each monkey in a pilot experiment. All assays included at least four and up to eight PBMC dilutions, and each dilution included at least 24 and up to 48 replicate wells of 96-well round-bottomed plates. Three or four aliquots from each well were tested in split-well cytotoxicity assays.
Cytotoxicity assay
Cytotoxicity was measured in standard "Cr-release assays against autologous and allogenic MHC class I mismatched B-LCL infected overnight with 10 m.o.i. of SW Gag or Tat rVV. Autologous B-LCL either infected with 186-poly rVV (containing a polycloning site without insert and kindly provided by Dr M.P. Kieny, Transgene) or incubated with medium alone served as control. Targets were labelled for 1 h with 100 &i of "'0, washed three times, resuspended in R-10, and added to effector cells at 5 x 10. cells per well in 96-well round-bottomed plates (Costar, Cambridge, UK). After a 5 h incubation, supernatants were harvested (Skatron Harvester, Skatron, Oslo, Norway), and the release of 5'Cr was measured in a gamma counter. Maximum 5'Cr release was determined by detergent (5% Triton X-100) lysis of target cells. Spontaneous release was determined by incubation of target cells in R-10 alone. Spontaneous release was <30% of maximum release.
Calculation of results
The percentage of lysis of specific and control targets was calculated for duplicate or triplicate wells of bulk cultures and for each well of limiting dilution cultures according to the formula: %lysis = [(experimental release -spontaneous release)/(maximum release -spontaneous release)] x 100. Individual wells of limiting dilution cultures were considered positive when lysis of specific targets exceeded by 10% that of control targets if the latter was <lo%, or by 20% if the latter was > 10%. In all positive wells the experimental release exceeded the spontaneous release by at least three standard deviations (S.D.). CTLp frequencies were estimated by the maximum likelihood method using the statistical software packa e described by Strijbosch et al."', 9 which included a x goodnessof-fit test statistic. Frequencies were normalized to the number of CTLp per 10h PBMC. Rates of change/ month of follow-up (slopes), and correlation coefficients (r) of virus load, CTLp frequencies and CD4+ cell percentages were calculated by linear regression analysis.
RESULTS
Measurement of SIV Gag-specific CTL in bulk assays
SW Gag-specific CTL responses were studied in eight cynomolgus macaques during the first 4 months of infection with SIVmac32H(JS). Four monkeys (indi-
cated by an asterisk) had been immunized before infection with an SIV Env-Iscoms, Gag-Iscoms and Nef-lipopetides subunit vaccine4, whereas the other four animals were naive at time of virus inoculation. To establish optimal conditions for CTL measurement, we first compared in bulk assays the direct SIV Gag-specific CTL responses of unstimulated PBMC with those mediated by the same PBMC following either mitogenic or antigenic in vitro restimulation. As shown in the examples of Figure lA , no significant CTL responses against SIV Gag were mediated by unstimulated PBMC in E:T ratios up to 2OO:l. After mitogenic expansion with ConA ( Figure ZB) , effector cells specifically reactive against SW Gag were detected in monkey K71, whereas relatively high levels of non-specific background lysis hindered reliable CTL measurement in monkey K88*. In parallel, the specific lysis of SIV Gag rVV-infected targets was markedly enhanced by two l-week cycles of antigenic stimulation, using as APC autologous pfa-fixed B-LCL infected with SIV Gag rVV ( Figure IC) .
Previously we'" and others"' have shown that after pfa-fixation, Epstein-Barr virus-transformed B-LCL retain their ability to induce CTL activation, but lose their release of helper-like soluble factors. These factors are known to stimulate the growth of both MHC restricted and unrestricted cytotoxic cells reactive against the B-LCL'"."'. Extending these observations to Herpes papio-transformed B-LCL, we observed that stimulation of PBMC from monkey K88* with pfa-fixed SIV Gag APC elicited SIV Gag-specific For cold target inhibition (C), non-labelled uninfected B-LCL were mixed with the "Cr-labelled targets at a ratio of 51 before the CTL assay was initiated. Results are expressed as mean specific lysis with SD. from duplicate well estimations at an E:T ratio of 4O:l CTL without significant expansion of cytotoxic cells reactive against control targets (Figure 2A ). In contrast, after stimulation of the same PBMC with irradiated SIV Gag APC ( Figure 2B and C), relatively high numbers of cold (non-5'Cr-labelled) uninfected targets were required to inhibit non-specific background lysis and measure SIV Gag-specific CTL.
In monkey K71, effector cells generated by stimulation with either SIV Gag ( Figure 3A) or Tat ( Figure  3B ) APC mediated significant lysis of targets infected with the inducing rVV, but not of targets infected with either the discordant rVV or with vaccinia virus control. This finding confirmed that antigenic stimulation induces selective CTL activation. Furthermore, immunofluorescence analyses indicated an expansion of CD8' cells at the end of the two cycles of SIV Gag-specific stimulation (data not shown). Depletion studies confirmed that SIV Gag-specific CTL were indeed CD8' cells: as shown in Figure 4 for monkey K71, SIV Gag-specific CTL responses mediated by total effector cells were preserved in positively isolated CD8' cells, but were abolished by CD8-depletion. In addition, these responses were restricted to autologous targets, whereas allogenic MHC class-I mismatched targets infected with SIV Gag rVV were not recognized. and MHC-restricted cytotoxic responses against SIV Gag. Effector cells generated by stimulation of PBMC from monkey K71 with SIV Gag APC were assayed as total cell population, positively isolated CD8' cells (>99% CDB'), and CD8-depleted cell population (<2% CD8'). Targets were autologous B-LCL infected with either SIV Gag rW or with vaccinia virus (w) control, and allogenic SIV Gag rW-infected B-LCL from three MHC class-l mismatched monkeys
Measurement of SW Gag-specific CTL and CTLp in limiting dilution assays
The frequencies of SIV Gag-specific CTL and CTLp were estimated by limiting dilution assays of unstimulated and restimulated PBMC, respectively. The optimal assay parameters (i.e. numbers and ranges of dilutions and numbers of replicate wells) yielding x" goodness-of-fit test statistic < 10 were predetermined in a pilot experiment for each monkeys. Single-well cytotoxic responses of restimulated PBMC from monkey K71 are shown in Figure 5 . In agreement with the results of bulk CTL assays (Figure IC) , after two l-week cycles of SIV Gag-specific stimulation, effector cells in most wells mediated killing of SIV Gag rVV-infected targets ( Figure 5A ), with negligible killing of control targets ( Figure 5B) . The relationship between the percentage of negative wells and the initial cell number was consistent with the single-hit Poisson model and indicated a CTLp frequency of 58 (95% confidence interval: 44-72; x1:1) per 10" PBMC ( Figure  X, filled circles) . In contrast, in the absence of PBMC restimulation, SIV Gag-specific CTL were detected at a frequency of only two (0.3-3; x2:1) per 10" PBMC ( Figure 5C , filled triangles). Similarly, 4 months after infection, the frequency of SIV Gag-specific CTL in unstimulated PBMC of monkey K88* was only 2 (0.4-4; x2:4) per 10" PBMC, whereas no CTL could be detected in unstimulated PBMC of other monkeys (data not shown). These findings confirmed that in vitro restimulation greatly amplifies SIV Gag-specific CTL responses.
Cell culture under limiting dilution conditions further increased the sensitivity of CTL measurement. Even after SIV Gag-specific PBMC restimulation, monkeys with low, but still measurable CTLp frequencies (< 10 per 10" PBMC), showed no consistent CTL responses in standard bulk CTL assays, using E:T ratios up to 1OO:l. As an example, a comparison of bulk and limiting dilution assays of PBMC from monkey K66 is shown in Figure 6 . In bulk assays ( Figure  6A ), no significant lysis of SIV Gag rVV-infected targets was mediated by PBMC that were unstimulated or restimulated with either ConA or SIV-infected blasts. Lysis increased after SIV Gag-specific stimula- tion, but it was still ~10% after subtraction of non-specific background lysis. In limiting dilution assays, SIV Gag-specific CTLp were detected at a frequency of four (2-6; x": 1) per 10" PBMC ( Figure  6B ).
The reproducibility of CTLp frequency estimates was verified in 10 replicate assays of cryopreserved PBMC, which showed a mean coefficient of variation (as 100 x the S.D. of the residuals/mean CTLp frequency estimate) of 9.5% (data not shown). We also investigated the ability of SIV Gag APC to stimulate unprimed CTLp in naive PBMC isolated from the eight monkeys before exposure to either whole SIV or SIV antigens. These PBMC were assayed in parallel with those obtained 4 months after infection, using identical culture and assay conditions. The individual wells of limiting dilution assays were never or rarely positive in naive PBMC (CTLp frequencies < 1 per 10" (A and B) or uninfected (medium control, B) . The frequency of SIV Gag-specific CTLp was 4 (2-6; x2:1) per lo6 PBMC PBMC, data not shown), indicating that only primed CTLp were responsive to SIV Gag-specific stimulation.
Kinetics of SIV Gag-specific CTLp
In kinetic studies of the four monkeys that were naive at the time of virus inoculation, SIV Gag-specific CTLp were first detected between week 1 and 4 (K71, K73, K79) or 9 (K66) after infection (Table 1) . CTLp detection in circulation coincided therefore with the containment of PBMC-associated virus load and p26 antigenemia which followed the initial virus burst observed at week 2 or 4 after infection". The four vaccinated monkeys (K77*, K80*, K83* and K88*) had developed SIV Gag-specific CTLp upon immunization, at frequencies ranging from 2 to 13 per 10" PBMC". After infection, their CTLp frequencies were still similar to those found in the non-immunized animals ( Table 2 ). In all eight monkeys, frequencies were generally maintained between week 12 and 4 months after infection, but a marked increase was observed in monkey K88*. Overall, no clear correlation emerged between CTLp frequencies and PBMC-associated virus load. In fact, 4 months after infection statistical analysis seemed to suggest a strong positive correlation between virus load and CTLp frequencies (r = 0.89, P = 0.003, not shown); however, this relationship was lost if monkey K88* was excluded from analysis. All eight monkeys remained asymptomatic during the first 4 months of infection. Six animals showed a progressive decline of CD4' cell percentages, which was pronounced in monkeys K73 and K79 (Table I) .
DISCUSSION
In the present study, we have studied the CTL responses of immunized and naive cynomolgus monkeys after infection with SIVmac32H(JS).
We focused our attention on responses directed against the relatively conserved Gag protein, which has been described as a major target of CTL immunity against lentiviruses".".". Our findings demonstrate that antigenie stimulation of effector cells under limiting dilu- (Figure 6 ).
In vitro restimulation was shown to be required to amplify SIV Gag-specific CTL responses to detectable levels ( Figure  1 ). In contrast, Gag-specific CTL responses of asymptomatic HIV-1 -infected adults have often been of sufficient magnitude to allow detection in primary assays, in the absence of in vitro restimulation".".
In line with these observations, and in agreement with previous studies of SIVmac-infected rhesus"," and cynomolgus"' macaques, SIV Figure I ), a well-established method for CTL expansion".
Other authors have also reported the use of rVV to expand CTL against HIV" or SIV'" antigens. In the study by Lubaki et a1.'5, the use of irradiated rVV-infected B-LCL as APC caused high levels of non-specific background lysis, and cold target inhibition was required to detect HIV-specific CTL. In our study, PBMC stimulation with irradiated SIV Gag APC also allowed CTL detection in bulk assays when combined with cold target inhibition (Figure 2 ). However, this method did not allow a reproducible measurement of CTLp frequencies in limiting dilution assays (data not shown). Along the same line, Kent et al. '" had to replace irradiated rVV-infected B-LCL with irradiated rVV-infected PBMC as APC to reduce the growth of non-specific cytotoxic cells and measure SIV-specific CTL. The improved ratio of specific to non-specific lysis we obtained with pfa-fixed APC (Figure 2 ), probably resulted from an adequate preservation of their stimulation efficiency, together with a reduced release of T-helper like soluble factors that may stimulate the growth of non-SIV-specific cytotoxic cells'3.Z". Interestingly, a previous study by Venet et al." described an earlier development of SIV-induced disease in those monkeys which lacked detectable CTL responses.
All our monkeys remained asymptomatic during the first 6 months of observation.
Among the six animals with relatively low CTLp frequencies, five showed a progressive decrease of CD4' cell percentages, which was pronounced in only two cases (Tahlr I). Nonetheless, a longer follow-up may clarify whether the generation of higher SIV Gag-specific CTLp frequencies may be associated with a better long-term control of the infection in some monkeys. Studies are in progress to address this hypothesis, which may contribute to the design of effective vaccina-
